VaxSyna is developing a novel vaccine platform that is highly immunogenic, thermally stable and is an easily modifiable platform to rapidly develop vaccines and therapeutics to address infectious diseases. Our leading products are vaccines targeting Herpes simplex virus and HPV.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Boston, Us
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.vaxsyna.com/
- Keywords
- Research, Antibody therapeutics, Vaccines, HPV, Vaccine Development, Plant Expression, Protein Production, Herpes, Herpes Simplex Virus, Vaccine manufacturing.
- HQ
- Boston
Vaxsyna, Inc Questions
Vaxsyna, Inc's website is https://www.vaxsyna.com/
Vaxsyna, Inc's LinkedIn profile is https://www.linkedin.com/company/vaxsyna-inc
Vaxsyna, Inc has
5 employees.
View email and phone details for 5
employees at Vaxsyna, Inc.
Vaxsyna, Inc's industry is
Research Services
Vaxsyna, Inc's top competitors are
Biokresko,
Rykotech,
Codonify,
Bebop Labs,
Calviri,
Riviobio, Inc.,
Mgenerx,
College Hero,
Bebop Labs Nonprofit,
Justmilk.
Vaxsyna, Inc's categories are Research Services
Vaxsyna, Inc's founding year is 2020
